Page last updated: 2024-09-03

ginsenoside rh2 and elacridar

ginsenoside rh2 has been researched along with elacridar in 1 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(elacridar)
Trials
(elacridar)
Recent Studies (post-2010) (elacridar)
29512002848119

Protein Interaction Comparison

ProteinTaxonomyginsenoside rh2 (IC50)elacridar (IC50)
ATP-dependent translocase ABCB1Homo sapiens (human)0.4427
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)0.2852

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aa, JY; Cao, B; Ge, C; Gu, RR; Li, MJ; Liu, CX; Liu, LS; Ma, T; Mao, Y; Shi, J; Sun, RB; Wang, GJ; Wang, XW; Wu, XL; Xia, WJ; Xiao, WJ; Yu, XY; Zha, WB; Zheng, T; Zhou, J1

Other Studies

1 other study(ies) available for ginsenoside rh2 and elacridar

ArticleYear
Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo.
    Acta pharmacologica Sinica, 2013, Volume: 34, Issue:10

    Topics: Acridines; Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Chromatography, Liquid; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Ginsenosides; HIV Protease Inhibitors; Humans; Injections, Intravenous; Madin Darby Canine Kidney Cells; Male; Mass Spectrometry; Rats; Rats, Wistar; Ritonavir; Tetrahydroisoquinolines; Tissue Distribution; Verapamil

2013